CASE STUDY: Personal Experience as a Physician and Anti- MOG Positive Neuromyelitis Optica Patient (MOGAD)
Dr. Estrella Rodríguez*
Neuroimmunologist, NMOSD & MOGAD Specialist, Health consultant, Spain.
*Corresponding Author: Dr. Rodríguez Estrella, Neuroimmunologist, NMOSD & MOGAD Specialist, Health consultant, Spain.
DOI: https://doi.org/10.58624/SVOANE.2024.05.0137
Received: April 14, 2024 Published: May 06, 2024
Abstract
Neuromyelitis Optica (NMO) is a rare demyelinating disease, recently segregated from other demyelinating diseases due to its distinctive features that set it apart from multiple sclerosis (MS) and other central nervous system (CNS) disorders. Particularly, the presence of autoantibodies against myelin oligodendrocyte glycoprotein (MOG) has emerged as a specific subtype of NMO, known as MOGAD. This article presents a unique case in which a physician, with a specialization in neuroimmunology, personally experiences the challenges of delayed diagnosis and clinical management of this disease.
Keywords: Neuromyelitis Optica, MOGAD, Delayed diagnosis, Symptomatic treatment, Medical awareness, Clinical protocol modification, Empathy, Pain, Anti-MOG.
Citation: Rodríguez E. CASE STUDY: Personal Experience as a Physician and Anti- MOG Positive Neuromyelitis Optica Patient (MOGAD). SVOA Neurology 2024, 5:3, 108-125.
